225 related articles for article (PubMed ID: 20218792)
1. The first- and second-generation antipsychotic drugs affect ADP-induced platelet aggregation.
Dietrich-Muszalska A; Rabe-Jablonska J; Nowak P; Kontek B
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):268-75. PubMed ID: 20218792
[TBL] [Abstract][Full Text] [Related]
2. The effects of the second generation antipsychotics and a typical neuroleptic on collagen-induced platelet aggregation in vitro.
Dietrich-Muszalska A; Rabe-Jabłońska J; Olas B
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):293-9. PubMed ID: 19675971
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of antipsychotics on human platelet adhesion and aggregation and plasma coagulation.
Axelsson S; Hägg S; Eriksson AC; Lindahl TL; Whiss PA
Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):775-80. PubMed ID: 17600556
[TBL] [Abstract][Full Text] [Related]
4. The changes of aggregability of blood platelets in schizophrenia.
Dietrich-Muszalska A; Olas B
World J Biol Psychiatry; 2009; 10(2):171-6. PubMed ID: 19514099
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic Drugs Inhibit Platelet Aggregation via P2Y 1 and P2Y 12 Receptors.
Wu CC; Tsai FM; Chen ML; Wu S; Lee MC; Tsai TC; Wang LK; Wang CH
Biomed Res Int; 2016; 2016():2532371. PubMed ID: 27069920
[TBL] [Abstract][Full Text] [Related]
6. Schizophrenic patients treated with clozapine or olanzapine perform better on theory of mind tasks than those treated with risperidone or typical antipsychotic medications.
Savina I; Beninger RJ
Schizophr Res; 2007 Aug; 94(1-3):128-38. PubMed ID: 17560766
[TBL] [Abstract][Full Text] [Related]
7. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
Citrome L; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; McEvoy J; Cooper TB; Chakos M; Lieberman JA
Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein.
Wang JS; Zhu HJ; Markowitz JS; Donovan JL; DeVane CL
Psychopharmacology (Berl); 2006 Sep; 187(4):415-23. PubMed ID: 16810505
[TBL] [Abstract][Full Text] [Related]
9. The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.
Assié MB; Carilla-Durand E; Bardin L; Maraval M; Aliaga M; Malfètes N; Barbara M; Newman-Tancredi A
Eur J Pharmacol; 2008 Sep; 592(1-3):160-6. PubMed ID: 18640111
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.
Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA
J Pharmacol Exp Ther; 2000 Apr; 293(1):8-14. PubMed ID: 10734147
[TBL] [Abstract][Full Text] [Related]
11. Novel antipsychotics: comparison of weight gain liabilities.
Wirshing DA; Wirshing WC; Kysar L; Berisford MA; Goldstein D; Pashdag J; Mintz J; Marder SR
J Clin Psychiatry; 1999 Jun; 60(6):358-63. PubMed ID: 10401912
[TBL] [Abstract][Full Text] [Related]
12. Effects of typical and atypical antipsychotics on human glycine transporters.
Williams JB; Mallorga PJ; Conn PJ; Pettibone DJ; Sur C
Schizophr Res; 2004 Nov; 71(1):103-12. PubMed ID: 15374578
[TBL] [Abstract][Full Text] [Related]
13. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
Kapur S; Zipursky RB; Remington G
Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
Crespo-Facorro B; Rodríguez-Sánchez JM; Pérez-Iglesias R; Mata I; Ayesa R; Ramirez-Bonilla M; Martínez-Garcia O; Vázquez-Barquero JL
J Clin Psychiatry; 2009 Apr; 70(5):717-29. PubMed ID: 19389335
[TBL] [Abstract][Full Text] [Related]
15. Effects of antipsychotic drugs on operant responding after acute and repeated administration.
Varvel SA; Vann RE; Wise LE; Philibin SD; Porter JH
Psychopharmacology (Berl); 2002 Mar; 160(2):182-91. PubMed ID: 11875636
[TBL] [Abstract][Full Text] [Related]
16. Clozapine and olanzapine are better antioxidants than haloperidol, quetiapine, risperidone and ziprasidone in in vitro models.
Brinholi FF; Farias CC; Bonifácio KL; Higachi L; Casagrande R; Moreira EG; Barbosa DS
Biomed Pharmacother; 2016 Jul; 81():411-415. PubMed ID: 27261620
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
Bilder RM; Goldman RS; Volavka J; Czobor P; Hoptman M; Sheitman B; Lindenmayer JP; Citrome L; McEvoy J; Kunz M; Chakos M; Cooper TB; Horowitz TL; Lieberman JA
Am J Psychiatry; 2002 Jun; 159(6):1018-28. PubMed ID: 12042192
[TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice.
Sugino H; Futamura T; Mitsumoto Y; Maeda K; Marunaka Y
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):303-7. PubMed ID: 19138716
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of aripiprazole and selected antipsychotic drugs on lipid peroxidation in plasma.
Dietrich-Muszalska A; Kolińska-Łukaszuk J
Psychiatry Clin Neurosci; 2018 May; 72(5):329-336. PubMed ID: 29280533
[TBL] [Abstract][Full Text] [Related]
20. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
